{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T21:11:42Z","timestamp":1724879502136},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Public health measures instituted at the onset of the COVID-19 pandemic in the UK in 2020 had profound effects on the cancer patient pathway. We hypothesise that this may have affected analgesic prescriptions for cancer patients in primary care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A whole-nation retrospective, observational study of opioid and antineuropathic analgesics prescribed in primary care for two cohorts of cancer patients in Wales, using linked anonymised data to evaluate the impact of the pandemic and variation between different demographic backgrounds.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found a significant increase in strong opioid prescriptions during the pandemic for patients within their first 12 months of diagnosis with a common cancer (incidence rate ratio (IRR) 1.15, 95% CI: 1.12\u20131.18, <jats:italic>p<\/jats:italic> &lt; 0.001 for strong opioids) and significant increases in strong opioid and antineuropathic prescriptions for patients in the last 3 months prior to a cancer-related death (IRR = 1.06, 95% CI: 1.04\u20131.07, <jats:italic>p<\/jats:italic> &lt; 0.001 for strong opioids; IRR = 1.11, 95% CI: 1.08\u20131.14, <jats:italic>p<\/jats:italic> &lt; 0.001 for antineuropathics). A spike in opioid prescriptions for patients diagnosed in Q2 2020 and those who died in Q2 2020 was observed and interpreted as stockpiling. More analgesics were prescribed in more deprived quintiles. This differential was less pronounced in patients towards the end of life, which we attribute to closer professional supervision.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We demonstrate significant changes to community analgesic prescriptions for cancer patients related to the UK pandemic and illustrate prescription patterns linked to patients\u2019 demographic background.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-023-07944-8","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T07:02:12Z","timestamp":1692687732000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of the COVID-19 pandemic on community prescription of opioid and antineuropathic analgesics for cancer patients in Wales, UK"],"prefix":"10.1007","volume":"31","author":[{"given":"Jun","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Rolles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Torabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowena","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Bedston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giles","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamsin","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyfed Wyn","family":"Huws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan A","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"issue":"1","key":"7944_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/j.pain.0000000000001363","volume":"160","author":"MI Bennett","year":"2019","unstructured":"Bennett MI, Kaasa S, Barke A et al (2019) The IASP classification of chronic pain for ICD-11: chronic cancer-related pain. Pain 160(1):38\u201344. https:\/\/doi.org\/10.1097\/j.pain.0000000000001363","journal-title":"Pain"},{"key":"7944_CR2","volume-title":"Facts about cancer pain","author":"AC Society","year":"2019","unstructured":"American Cancer Society (2019) Facts about cancer pain. URL: https:\/\/www.cancer.org\/treatment\/treatments-and-side-effects\/physical-side-effects\/pain\/facts-about-cancer-pain.html. Accessed 1 Feb 2022"},{"key":"7944_CR3","volume-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents 2019","author":"World Health Organization","year":"2019","unstructured":"World Health Organization (2019) WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents 2019. URL: https:\/\/www.who.int\/publications\/i\/item\/97892415503908. Accessed 1 Feb 2022"},{"key":"7944_CR4","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F et al (2018) Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 29:iv166\u2013iv191. https:\/\/doi.org\/10.1093\/annonc\/mdy152","journal-title":"Ann Oncol"},{"issue":"3","key":"7944_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/cancers11030373","volume":"11","author":"H Edwards","year":"2019","unstructured":"Edwards H, Mulvey M, Bennett M (2019) Cancer-related neuropathic pain. Cancers 11(3):373\u2013341. https:\/\/doi.org\/10.3390\/cancers11030373","journal-title":"Cancers"},{"issue":"1","key":"7944_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s40265-022-01675-6","volume":"29","author":"R Mitra","year":"2012","unstructured":"Mitra R, Jones S (2012) Adjuvant analgesics in cancer pain: a review. Am J Hosp Palliat Care 29(1):70\u201379. https:\/\/doi.org\/10.1007\/s40265-022-01675-6","journal-title":"Am J Hosp Palliat Care"},{"issue":"3","key":"7944_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40265-022-01675-6","volume":"82","author":"P Glare","year":"2022","unstructured":"Glare P, Aubrey K, Gulati A et al (2022) Pharmacologic management of persistent pain in cancer survivors. Drugs 82(3):275\u2013291","journal-title":"Drugs"},{"key":"7944_CR8","doi-asserted-by":"publisher","first-page":"9781","DOI":"10.1007\/s00520-022-07439-y","volume":"30","author":"DK Check","year":"2022","unstructured":"Check DK, Baggett CD, Kim K et al (2022) Concurrent prescribing of opioids with other sedating medications after cancer diagnosis: a population-level analysis. Support Care Cancer 30:9781\u20139791. https:\/\/doi.org\/10.1007\/s00520-022-07439-y","journal-title":"Support Care Cancer"},{"issue":"8","key":"7944_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","volume":"21","author":"C Maringe","year":"2020","unstructured":"Maringe C, Spicer J, Morris M et al (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21(8):1023\u20131034. https:\/\/doi.org\/10.1016\/S1470-2045(20)30388-0","journal-title":"Lancet Oncol"},{"key":"7944_CR10","volume-title":"The Lasting Impact of COVID-19 on Death, Dying and Bereavement","author":"All-Party Parliamentary Group: Hospice and End of Life Care","year":"2023","unstructured":"All-Party Parliamentary Group: Hospice and End of Life Care (2023) The Lasting Impact of COVID-19 on Death, Dying and Bereavement. https:\/\/hukstage-new-bucket.s3.eu-west-2.amazonaws.com\/s3fs-public\/2023-02\/FinalAPPGreport.pdf?VersionId=nIC3UxdxrAtZ2g8ak.ZjcMwmS5rTGN6K . Accessed 12 May 2023"},{"key":"7944_CR11","volume-title":"COVID-19 rapid guideline: delivery of systemic anticancer treatments [NG61]","author":"National Institute for Health and Care Excellence","year":"2020","unstructured":"National Institute for Health and Care Excellence (2020) COVID-19 rapid guideline: delivery of systemic anticancer treatments [NG61]. https:\/\/www.nice.org.uk\/guidance\/ng161. Accessed 22 Aug 2022."},{"issue":"5","key":"7944_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(20)30217-5","volume":"21","author":"TK Burki","year":"2020","unstructured":"Burki TK (2020) Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 21(5):629\u2013630. https:\/\/doi.org\/10.1016\/S1470-2045(20)30217-5","journal-title":"Lancet Oncol"},{"key":"7944_CR13","volume-title":"CANCER - 20200407 - Cancer services in Wales during COVID","author":"NHS Wales","year":"2020","unstructured":"NHS Wales (2020) CANCER - 20200407 - Cancer services in Wales during COVID. URL: http:\/\/www.wales.nhs.uk\/document\/361708\/info. Accessed 22 Aug 2022."},{"key":"7944_CR14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/02692163211000660","volume":"35","author":"L Dunleavy","year":"2021","unstructured":"Dunleavy L, Preston N, Bajwah S et al (2021) \u2018Necessity is the mother of invention\u2019: Specialist palliative care service innovation and practice change in response to COVID-19. Results from a multinational survey (CovPall). Palliat Med 35:814\u2013829. https:\/\/doi.org\/10.1177\/02692163211000660","journal-title":"Palliat Med"},{"issue":"1","key":"7944_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1470-2045(20)30619-7","volume":"22","author":"JJ Clark","year":"2021","unstructured":"Clark JJ, Dwyer D, Pinwill N et al (2021) The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis. Lancet Oncol. 22(1):66\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(20)30619-7","journal-title":"Lancet Oncol."},{"issue":"3","key":"7944_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41416-022-01830-6","volume":"127","author":"G Greene","year":"2022","unstructured":"Greene G, Griffiths R, Han J et al (2022) Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small\u00a0cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system. Br J Cancer 127(3):558\u2013568. https:\/\/doi.org\/10.1038\/s41416-022-01830-6","journal-title":"Br J Cancer"},{"issue":"3","key":"7944_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s2468-1253(21)00005-4","volume":"6","author":"EJA Morris","year":"2021","unstructured":"Morris EJA, Goldacre R, Spata E et al (2021) Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol Hepatol 6(3):199\u2013208. https:\/\/doi.org\/10.1016\/s2468-1253(21)00005-4","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7944_CR18","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3332\/ecancer.2021.1180","volume":"15","author":"A Purushotham","year":"2021","unstructured":"Purushotham A, Roberts G, Haire K et al (2021) The impact of national non-pharmaceutical interventions (\u2018lockdowns\u2019) on the presentation of cancer patients. Ecancermedicalscience 15:1180. https:\/\/doi.org\/10.3332\/ecancer.2021.1180","journal-title":"Ecancermedicalscience"},{"issue":"9","key":"7944_CR19","doi-asserted-by":"publisher","first-page":"e053095","DOI":"10.1136\/bmjopen-2021-053095","volume":"11","author":"HD Quinn-Scoggins","year":"2021","unstructured":"Quinn-Scoggins HD, Cannings-John R, Moriarty Y et al (2021) Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK: a cross-sectional population survey. BMJ Open 11(9):e053095. https:\/\/doi.org\/10.1136\/bmjopen-2021-053095","journal-title":"BMJ Open"},{"key":"7944_CR20","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1007\/s00520-021-06165-1","volume":"29","author":"M Brown","year":"2021","unstructured":"Brown M, O\u2019Connor D, Murphy C et al (2021) Impact of COVID-19 on an established physical activity and behaviour change support programme for cancer survivors: An exploratory survey of the Macmillan Move More service for Northern Ireland. Support Care Cancer 29:6135\u20136143. https:\/\/doi.org\/10.1007\/s00520-021-06165-1","journal-title":"Support Care Cancer"},{"key":"7944_CR21","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1007\/s00520-021-06041-y","volume":"29","author":"S Colomer-Lahiguera","year":"2021","unstructured":"Colomer-Lahiguera S, Ribi K, Dunnack HJ et al (2021) Experiences of people affected by cancer during the outbreak of the COVID-19 pandemic: an exploratory qualitative analysis of public online forums. Support Care Cancer 29:4979\u20134985. https:\/\/doi.org\/10.1007\/s00520-021-06041-y","journal-title":"Support Care Cancer"},{"issue":"7","key":"7944_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/01410768221095245","volume":"115","author":"A Banerjee","year":"2022","unstructured":"Banerjee A, Sudlow C, Lawler M (2022) Indirect effects of the pandemic: highlighting the need for data-driven policy and preparedness. J R Soc Med 115(7):249\u2013251. https:\/\/doi.org\/10.1177\/01410768221095245","journal-title":"J R Soc Med"},{"key":"7944_CR23","doi-asserted-by":"publisher","first-page":"o282","DOI":"10.1136\/bmj.o282","volume":"376","author":"M Lawler","year":"2022","unstructured":"Lawler M, Crul M (2022) Data must underpin our response to the covid-19 pandemic's disastrous impact on cancer. BMJ 376:o282. https:\/\/doi.org\/10.1136\/bmj.o282","journal-title":"BMJ"},{"issue":"6","key":"7944_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/17512433.2022.2093715","volume":"15","author":"O Nawaf Sindi","year":"2022","unstructured":"Nawaf Sindi O, Alshaikh FS, Godman B et al (2022) The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilization of opioids in the English primary care setting: segmented-liner regression analysis. Expert Rev Clin Pharmacol 15(6):787\u2013793. https:\/\/doi.org\/10.1080\/17512433.2022.2093715","journal-title":"Expert Rev Clin Pharmacol"},{"key":"7944_CR25","doi-asserted-by":"publisher","first-page":"215013192210769","DOI":"10.1177\/21501319221076926","volume":"13","author":"S Rikin","year":"2022","unstructured":"Rikin S, Perez HR, Zhang C et al (2022) Changes in outpatient opioid prescribing during the COVID-19 pandemic: an interrupted time series snalysis. J Prim Care Community Health 13:21501319221076926. https:\/\/doi.org\/10.1177\/21501319221076926","journal-title":"J Prim Care Community Health"},{"issue":"1","key":"7944_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6947-9-3","volume":"9","author":"RA Lyons","year":"2009","unstructured":"Lyons RA, Jones KH, John G et al (2009) The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak 9(1):3. https:\/\/doi.org\/10.1186\/1472-6947-9-3","journal-title":"BMC Med Inform Decis Mak"},{"key":"7944_CR27","doi-asserted-by":"publisher","first-page":"e047101","DOI":"10.1136\/bmjopen-2020-047101","volume":"11","author":"J Lyons","year":"2021","unstructured":"Lyons J, Akbari A, Agrawal U et al (2021) Protocol for the development of the Wales Multimorbidity e-Cohort (WMC): data sources and methods to construct a population-based research platform to investigate multimorbidity. BMJ Open 11:e047101. https:\/\/doi.org\/10.1136\/bmjopen-2020-047101","journal-title":"BMJ Open"},{"key":"7944_CR28","volume-title":"Clinical coding classification systems and maps: primary care codings","author":"UK Biobank","year":"2019","unstructured":"UK Biobank (2019) Clinical coding classification systems and maps: primary care codings. URL: https:\/\/biobank.ndph.ox.ac.uk\/showcase\/refer.cgi?id=592. Accessed 24 Apr 2022"},{"key":"7944_CR29","volume-title":"Welsh Index of Multiple Deprivation (full index update with ranks): 2019","author":"Welsh Government","year":"2019","unstructured":"Welsh Government (2019) Welsh Index of Multiple Deprivation (full index update with ranks): 2019. URL: https:\/\/gov.wales\/welsh-index-multiple-deprivation-full-index-update-ranks-2019. Accessed 25 Aug 2022."},{"issue":"1","key":"7944_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12874-019-0753-5","volume":"19","author":"D Metcalfe","year":"2019","unstructured":"Metcalfe D, Masters J, Delmestri A et al (2019) Coding algorithms for defining Charlson and Elixhauser comorbidities in Read-coded databases. BMC Med Res Methodol 19(1):115. https:\/\/doi.org\/10.1186\/s12874-019-0753-5","journal-title":"BMC Med Res Methodol"},{"key":"7944_CR31","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1007\/s00520-019-05224-y","volume":"28","author":"CA Cuthbert","year":"2020","unstructured":"Cuthbert CA, Xu Y, Kong S et al (2020) Patient-level factors associated with chronic opioid use in cancer: a population-based cohort study. Support Care Cancer 28:4201\u20134209. https:\/\/doi.org\/10.1007\/s00520-019-05224-y","journal-title":"Support Care Cancer"},{"key":"7944_CR32","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2022","unstructured":"R Core Team (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria URL: https:\/\/www.R-project.org"},{"key":"7944_CR33","volume-title":"Maintaining a cancer service in the midst of the COVID-19 pandemic: a single centre experience","author":"B Haematology","year":"2020","unstructured":"Bristol Haematology and Oncology Centre (2020) Maintaining a cancer service in the midst of the COVID-19 pandemic: a single centre experience. URL: https:\/\/www.nice.org.uk\/sharedlearning\/maintaining-a-cancer-service-in-the-midst-of-the-covid-19-pandemic-a-single-centre-experience. Accessed 10 May 2022"},{"issue":"4","key":"7944_CR34","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.23889\/ijpds.v5i4.1715","volume":"5","author":"F Torabi","year":"2022","unstructured":"Torabi F, Akbari A, Bedston S et al (2022) Impact of COVID-19 pandemic on community medication dispensing: a national cohort analysis in Wales. UK Int J Popul Data Sci 5(4):1715. https:\/\/doi.org\/10.23889\/ijpds.v5i4.1715","journal-title":"UK Int J Popul Data Sci"},{"key":"7944_CR35","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/fmch-2021-001143","volume":"9","author":"JS Frazer","year":"2021","unstructured":"Frazer JS, Frazer GR (2021) Analysis of primary care prescription trends in England during the COVID-19 pandemic compared against a predictive model. Fam Med Com Health 9:1143. https:\/\/doi.org\/10.1136\/fmch-2021-001143","journal-title":"Fam Med Com Health"},{"issue":"3","key":"7944_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/2049463718800737","volume":"13","author":"E Davies","year":"2019","unstructured":"Davies E, Phillips C, Rance J et al (2019) Examining patterns in opioid prescribing for non-cancer-related pain in Wales: preliminary data from a retrospective cross-sectional study using large datasets. Br J Pain 13(3):145\u2013158. https:\/\/doi.org\/10.1177\/2049463718800737","journal-title":"Br J Pain"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07944-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07944-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07944-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:10:53Z","timestamp":1694769053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07944-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["7944"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07944-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used in this study are pseudonymised patient data, and hence we did not require ethical approval in addition to our SAIL Information Governance Review Panel (IGRP) approvals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"JH, FT, RG, SB, AA, BB, JL, GG, RT, TL, CA and DWH have nothing to declare. MR and RAL are members of the Welsh Government COVID-19 Technical Advisory Group. ML has received honoraria unrelated to this work from Bayer, Carnall Farrar, EMD Serono, Novartis, Pfizer and Roche.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"531"}}